US Bancorp
YARW

US Bancorp’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

US Bancorp’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-89
Closed -$10.4K – 4109
2023
Q4 		$10.4K Hold
89
– – ﹤0.01% 3307
2023
Q3 		$18K Buy
+89
New +$19.4K ﹤0.01% 2936

Other funds holding YARW

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

US Bancorp's YARW Position: Q1 2024 in Review

US Bancorp sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2024, closing a stake of 89 shares — an estimated $10.4K sold.

US Bancorp first reported a position in YARW in Q3 2023 and held it in 2 quarters. The position peaked at $18K in Q3 2023. 30 funds tracked by Wall St. Rank hold YARW as of Q1 2024.

  • US Bancorp reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • US Bancorp sold 89 Yarrow Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $10.4K.
  • US Bancorp first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • US Bancorp's Yarrow Bioscience, Inc. Common Stock position peaked at $18K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2024.

Based on US Bancorp's 13F filing for Q1 2024, filed 8 May 2024.